RxDoctor Payments Data

Kaitlin Hinton

Nurse Practitioner · Laurel, MSNPI 1568089977

Payments from drug & device makers

$2,380in general payments, 2019–2025

Across 144 payments — averaging $16.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$779
  • AbbVie$344
  • Novo Nordisk$234
  • Lilly USA, LLC$167
  • Novartis$162
  • Boehringer Ingelheim$114
  • plus $580 from 18 others

What the payments were for

  • Food & beverage$2,380100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,380 in reported general payments places this provider in the 85th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$97,900
Medicare patients
293
Services billed
4,703

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin33$32,720
OzempicSemaglutide22$31,748
EliquisApixaban33$31,515
JanuviaSitagliptin Phosphate23$24,175
FarxigaDapagliflozin Propanediol27$21,915
XareltoRivaroxaban31$21,519
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog22$15,554
LinzessLinaclotide17$13,212
TrulicityDulaglutide13$12,051
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$11,161
MyrbetriqMirabegron13$9,157
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$7,062
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$4,424
Gabapentin207$2,341
Albuterol Sulfate HfaAlbuterol Sulfate57$1,825

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$114$32,72033 claims
Novo NordiskOzempic$234$31,74822 claims
PfizerEliquis$36$31,51533 claims
MerckJanuvia$84$24,17523 claims
AstraZenecaFarxiga$81$21,91527 claims
Johnson & JohnsonXarelto$16$21,51931 claims
AbbVieLinzess, Synthroid$344$13,99834 claims
Lilly USA, LLCTrulicity, Humulin 70-30$167$12,89125 claims
GSKTrelegy Ellipta$19$11,16114 claims
Astellas Pharma US IncMyrbetriq$14$9,15713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Laurel

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →